mGluR-4 Antibodies

Santa Cruz Biotechnology features a diverse variety of mGluR-4 monoclonal antibodies for research focused on understanding metabotropic glutamate receptor 4. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). mGluR-4 is a G protein-coupled receptor that plays a critical role in modulating synaptic transmission and neuronal excitability in the central nervous system. The involvement of mGluR-4 in various neurological disorders, including Parkinson's disease and schizophrenia, makes it an important target for potential therapeutic interventions. Understanding mGluR-4 function and regulation can provide insights into the complex mechanisms underlying these conditions. Researchers investigating mGluR-4 can utilize specific conjugates including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for enhanced detection flexibility. Advanced research in neurobiology and pharmacology continues to reveal new functions of mGluR-4 in neural signaling pathways. Current studies focus on how mGluR-4 influences neurotransmitter release and synaptic plasticity. Santa Cruz Biotechnology monoclonal antibodies for mGluR-4 enable researchers worldwide to advance scientific understanding of neurological disorders and potential treatments.